Day 2 Highlights from ASH 2024: Smoldering Myeloma, CLL Advances, and Ground Zero Insights
Curie: The Oncology Brief por Curie: The Platform for HCPs
Notas del episodio
Love what you hear? Download the Curie app from the App Store today.
Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals.
On Day 2 of ASH 2024, we explore breakthroughs in treating high-risk smoldering multiple myeloma, advancements in chronic lymphocytic leukemia therapies, and a revealing study on leukemia risk in Ground Zero first responders. Stay updated with insights that are reshaping hematology practice.
Palabras clave
podcastCancer diagnosticsHCPsDoctorsUSAASHMyelomaLeukemia